| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A common Chk1-dependent phenotype of DNA double-strand break suppression in two distinct radioresistant cancer types
|
Dinkelborg, Patrick H.
|
|
2019
|
174 |
3 |
p. 605-613
|
artikel
|
| 2 |
Age-specific risks of incident, contralateral and ipsilateral breast cancer among 1776 Polish BRCA1 mutation carriers
|
Lubinski, Jan
|
|
2019
|
174 |
3 |
p. 769-774
|
artikel
|
| 3 |
Aromatase inhibitor and tamoxifen use and the risk of venous thromboembolism in breast cancer survivors
|
Xu, Xiaoqing
|
|
2019
|
174 |
3 |
p. 785-794
|
artikel
|
| 4 |
BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients
|
Friedlaender, Alex
|
|
2019
|
174 |
3 |
p. 775-783
|
artikel
|
| 5 |
Clinical implications of germline mutations in breast cancer genes: RECQL
|
Bowden, A. Ramsay
|
|
2019
|
174 |
3 |
p. 553-560
|
artikel
|
| 6 |
Clinicopathological analysis of homologous recombination-deficient breast cancers with special reference to response to neoadjuvant paclitaxel followed by FEC
|
Imanishi, Seiichi
|
|
2019
|
174 |
3 |
p. 627-637
|
artikel
|
| 7 |
Comparative efficacy of palbociclib, ribociclib and abemaciclib for ER+ metastatic breast cancer: an adjusted indirect analysis of randomized controlled trials
|
Petrelli, Fausto
|
|
2019
|
174 |
3 |
p. 597-604
|
artikel
|
| 8 |
Comparison of treatment of early-stage breast cancer among Nurses’ Health Study participants and other Medicare beneficiaries
|
Austin, Andrea M.
|
|
2019
|
174 |
3 |
p. 759-767
|
artikel
|
| 9 |
Efficacy and safety of dasatinib with trastuzumab and paclitaxel in first line HER2-positive metastatic breast cancer: results from the phase II GEICAM/2010-04 study
|
Ocana, Alberto
|
|
2019
|
174 |
3 |
p. 693-701
|
artikel
|
| 10 |
Epithelial-to-mesenchymal transition status of primary breast carcinomas and its correlation with metastatic behavior
|
Savci-Heijink, C. D.
|
|
2019
|
174 |
3 |
p. 649-659
|
artikel
|
| 11 |
Expression of Lamin A/C in early-stage breast cancer and its prognostic value
|
Alhudiri, I. M.
|
|
2019
|
174 |
3 |
p. 661-668
|
artikel
|
| 12 |
Extracapsular extension in the positive sentinel lymph node: a marker of poor prognosis in cT1-2N0 breast cancer patients?
|
Vane, Marissa L. G.
|
|
2019
|
174 |
3 |
p. 711-718
|
artikel
|
| 13 |
Folic acid supplement use and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a case–control study
|
Kim, Shana J.
|
|
2019
|
174 |
3 |
p. 741-748
|
artikel
|
| 14 |
Health-related quality of life of breast cancer patients in the Eastern Mediterranean region: a systematic review and meta-analysis
|
Hashemi, Seyed-Mehdi
|
|
2019
|
174 |
3 |
p. 585-596
|
artikel
|
| 15 |
Is microductectomy still necessary to diagnose breast cancer: a 10-year study on the effectiveness of duct excision and galactography
|
Lustig, Daniel Ben
|
|
2019
|
174 |
3 |
p. 703-709
|
artikel
|
| 16 |
National consensus recommendations on patient-centered care for ductal carcinoma in situ
|
Gagliardi, Anna R.
|
|
2019
|
174 |
3 |
p. 561-570
|
artikel
|
| 17 |
Palbociclib and endocrine therapy in heavily pretreated hormone receptor-positive HER2-negative advanced breast cancer: the UK Compassionate Access Programme experience
|
Battisti, Nicolò Matteo Luca
|
|
2019
|
174 |
3 |
p. 731-740
|
artikel
|
| 18 |
Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up
|
Rugo, H. S.
|
|
2019
|
174 |
3 |
p. 719-729
|
artikel
|
| 19 |
PD-L1 expression in breast cancer: expression in subtypes and prognostic significance: a systematic review
|
Stovgaard, Elisabeth Specht
|
|
2019
|
174 |
3 |
p. 571-584
|
artikel
|
| 20 |
Pre-diagnostic sex hormone levels and survival among breast cancer patients
|
Kensler, Kevin H.
|
|
2019
|
174 |
3 |
p. 749-758
|
artikel
|
| 21 |
Prevalence and characterization of ATM germline mutations in Chinese BRCA1/2-negative breast cancer patients
|
Yang, Ziguo
|
|
2019
|
174 |
3 |
p. 639-647
|
artikel
|
| 22 |
Re-testing of predictive biomarkers on surgical breast cancer specimens is clinically relevant
|
Robertson, Stephanie
|
|
2019
|
174 |
3 |
p. 795-805
|
artikel
|
| 23 |
Re: The relationship between patient and tumor characteristics, patterns of breast cancer care, and 5-year survival among elderly women with incident breast cancer. Breast Cancer Res Treat. Sep 2018;171(2):477-488
|
Cheng, Elvin S.
|
|
2019
|
174 |
3 |
p. 807
|
artikel
|
| 24 |
Synergistic anti-cancer activity of CDK4/6 inhibitor palbociclib and dual mTOR kinase inhibitor MLN0128 in pRb-expressing ER-negative breast cancer
|
Yamamoto, Takuro
|
|
2019
|
174 |
3 |
p. 615-625
|
artikel
|
| 25 |
Three-dimensional tumor visualization of invasive breast carcinomas using whole-mount serial section histopathology: implications for tumor size assessment
|
Clarke, G. M.
|
|
2019
|
174 |
3 |
p. 669-677
|
artikel
|
| 26 |
Tumor microenvironmental plasmacytoid dendritic cells contribute to breast cancer lymph node metastasis via CXCR4/SDF-1 axis
|
Gadalla, Ramy
|
|
2019
|
174 |
3 |
p. 679-691
|
artikel
|
Tijdschrift beschrijving